Paul Devlin resigned as the CFO of Tissue Regenix Group plc.
The company's board will initiate a process to appoint a successor.
Tissue Regenix CFO resigns
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Paul Devlin resigned as the CFO of Tissue Regenix Group plc.
The company's board will initiate a process to appoint a successor.